JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 1997;50:106-109; doi:10.1136/jcp.50.2.106
Copyright © 1997 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shay, J W
Right arrow Articles by Gazdar, A F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shay, J W
Right arrow Articles by Gazdar, A F

Telomerase in the early detection of cancer.

J W Shay, A F Gazdar

Department of Cell Biology and Neuroscience, University of Texas Southwestern Medical Centre at Dallas 75235-9039, USA. Shay@utsw.swmed.edu

Although there is justifiable optimism regarding telomerase activity and early detection of cancer, it is important to point out that there is much that remains to be understood and additional validation studies will be required before knowledge of telomerase activity will be useful in decisions regarding patient management. A key question is whether we will be able to distinguish those cancers that are going to progress from those cancers that are not by detecting telomerase activity. Molecular staging using markers such as telomerase activity in combination with other molecular markers may be particularly useful in this regard. Basic scientists and clinicians must work together if this strategy is to mature. Telomerase inhibitors in the treatment of cancer are awaited with great anticipation.




This article has been cited by other articles:


Home page
JAMAHome page
M. A. Sanchini, R. Gunelli, O. Nanni, S. Bravaccini, C. Fabbri, A. Sermasi, E. Bercovich, A. Ravaioli, D. Amadori, and D. Calistri
Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer
JAMA, October 26, 2005; 294(16): 2052 - 2056.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. I. Botchkina, R. H. Kim, I. L. Botchkina, A. Kirshenbaum, Z. Frischer, and H. L. Adler
Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity
Clin. Cancer Res., May 1, 2005; 11(9): 3243 - 3249.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
J. P. Jakupciak, W. Wang, P. E. Barker, S. Srivastava, and D. H. Atha
Analytical Validation of Telomerase Activity for Cancer Early Detection: TRAP/PCR-CE and hTERT mRNA Quantification Assay for High-Throughput Screening of Tumor Cells
J. Mol. Diagn., August 1, 2004; 6(3): 157 - 165.
[Abstract] [Full Text]


Home page
JCOHome page
A. Ohali, S. Avigad, I.J. Cohen, I. Meller, Y. Kollender, J. Issakov, I. Gelernter, Y. Goshen, I. Yaniv, and R. Zaizov
Association Between Telomerase Activity and Outcome in Patients With Nonmetastatic Ewing Family of Tumors
J. Clin. Oncol., October 15, 2003; 21(20): 3836 - 3843.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Dikmen, E. Dikmen, M. Kara, E. Sahin, P. Dogan, and N. Ozdemir
Diagnostic implications of telomerase activity in pleural effusions
Eur. Respir. J., September 1, 2003; 22(3): 422 - 426.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Ikeda, H. Uemura, H. Ishiguro, M. Hori, M. Hosaka, S. Kyo, K.-i. Miyamoto, E. Takeda, and Y. Kubota
Combination Treatment with 1{alpha},25-Dihydroxyvitamin D3 and 9-cis-Retinoic Acid Directly Inhibits Human Telomerase Reverse Transcriptase Transcription in Prostate Cancer Cells
Mol. Cancer Ther., August 1, 2003; 2(8): 739 - 746.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Dikmen, M. Kara, G. Dikmen, H. Cakmak, and P. Dogan
Detection of telomerase activity in bronchial lavage as an adjunct to cytological diagnosis in lung cancer
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 194 - 199.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. W. Shay, Y. Zou, E. Hiyama, and W. E. Wright
Telomerase and cancer
Hum. Mol. Genet., April 1, 2001; 10(7): 677 - 685.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B.-S. Herbert, A. C. Wright, C. M. Passons, W. E. Wright, I. U. Ali, L. Kopelovich, and J. W. Shay
Effects of Chemopreventive and Antitelomerase Agents on the Spontaneous Immortalization of Breast Epithelial Cells
J Natl Cancer Inst, January 3, 2001; 93(1): 39 - 45.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Yan, J.-M. Coindre, J. Benhattar, F. T. Bosman, and L. Guillou
Telomerase Activity and Human Telomerase Reverse Transcriptase mRNA Expression in Soft Tissue Tumors: Correlation with Grade, Histology, and Proliferative Activity
Cancer Res., July 1, 1999; 59(13): 3166 - 3170.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. G. SAWANT, V. GREGOIRE, S. DHAR, C. B. UMBRICHT, S. CVILIC, S. SUKUMAR, and T. K. PANDITA
Telomerase activity as a measure for monitoring radiocurability of tumor cells
FASEB J, June 1, 1999; 13(9): 1047 - 1054.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
J.-C. Soria, L. R. Gauthier, E. Raymond, C. Granotier, L. Morat, J.-P. Armand, F. D. Boussin, and L. Sabatier
Molecular Detection of Telomerase-positive Circulating Epithelial Cells in Metastatic Breast Cancer Patients
Clin. Cancer Res., May 1, 1999; 5(5): 971 - 975.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. W. Shay
Toward Identifying a Cellular Determinant of Telomerase Repression
J Natl Cancer Inst, January 6, 1999; 91(1): 4 - 6.
[Full Text] [PDF]


Home page
JAMAHome page
M. Fossel
Telomerase and the Aging Cell: Implications for Human Health
JAMA, June 3, 1998; 279(21): 1732 - 1735.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1997 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.